TRINO, STEFANIA
 Distribuzione geografica
Continente #
NA - Nord America 600
EU - Europa 482
AS - Asia 303
AF - Africa 44
SA - Sud America 1
Totale 1.430
Nazione #
US - Stati Uniti d'America 600
GB - Regno Unito 150
VN - Vietnam 102
SE - Svezia 101
CN - Cina 96
SG - Singapore 64
DE - Germania 60
IT - Italia 60
IN - India 28
FR - Francia 23
IE - Irlanda 21
TG - Togo 21
CH - Svizzera 17
RU - Federazione Russa 15
ZA - Sudafrica 12
EE - Estonia 9
FI - Finlandia 6
UA - Ucraina 6
BE - Belgio 5
IR - Iran 5
NG - Nigeria 5
CI - Costa d'Avorio 4
BG - Bulgaria 3
JO - Giordania 3
PL - Polonia 3
AT - Austria 2
EG - Egitto 2
CL - Cile 1
HK - Hong Kong 1
JP - Giappone 1
KR - Corea 1
LB - Libano 1
NL - Olanda 1
UZ - Uzbekistan 1
Totale 1.430
Città #
Southend 138
Chandler 80
Dong Ket 70
Fairfield 70
Ashburn 58
Singapore 54
Ann Arbor 32
Woodbridge 30
Seattle 28
Princeton 25
Santa Clara 25
Wilmington 22
Dublin 21
Houston 21
Lomé 21
Bologna 16
Cambridge 16
Bern 15
Boardman 14
Florence 14
Nanjing 12
New York 12
Westminster 12
Beijing 11
Padova 11
Jinan 10
Turin 10
Medford 9
Saint Petersburg 7
Hebei 6
Helsinki 6
Shanghai 6
Shenyang 6
Abeokuta 5
Bremen 5
Brussels 5
Abidjan 4
Berlin 4
Redwood City 4
Amman 3
Changsha 3
Falls Church 3
Grafing 3
Mountain View 3
Mülheim 3
Nanchang 3
Sofia 3
Tehran 3
Cairo 2
Haikou 2
Hyderabad 2
Jiaxing 2
Kunming 2
Leawood 2
Los Angeles 2
Monmouth Junction 2
Mumbai 2
Ningbo 2
Norwalk 2
Paris 2
Pordenone 2
Rubano 2
San Diego 2
Tianjin 2
Bühl 1
Central 1
Cesena 1
Changchun 1
Chengdu 1
Chicago 1
Esslingen am Neckar 1
Forlì 1
Frankfurt Am Main 1
Frankfurt am Main 1
Fremont 1
Fuzhou 1
Guangzhou 1
Hangzhou 1
Jacksonville 1
Kiev 1
Las Vegas 1
Lincoln 1
London 1
Newark 1
Olalla 1
Orange 1
Peterborough 1
Plauen 1
Radomsko 1
Redmond 1
Roubaix 1
Shijiazhuang 1
Taiyuan 1
Tokyo 1
Vancouver 1
Warsaw 1
Waterford 1
Wuxi 1
Totale 1.008
Nome #
CDKN2A/B alterations impair prognosis in adult BCR-ABL1-positive acute lymphoblastic leukemia patients. 195
ARF Loss, a Negative Prognostic Factor in Philadelphia-Positive Acute Lymphoblastic Leukemia, May Be Efficiently Overcome by the Small Molecule MDM2 Antagonist RG7112 167
BCR-ABL1-Positive Acute Lymphoblastic Leukemia Patients Treated with Only TKI Vs Conventional Chemo Plus TKI Therapy Show Similar DNA Alterations At Relapse Targeting Key Regulators of Tumor Suppression, Cell Cycle Control, and Lymphoid/B-Cell Development 145
Targeting the p53-MDM2 interaction by the small-molecule MDM2 antagonist Nutlin-3a: A new challenged target therapy in adult Philadelphia positive acute lymphoblastic leukemia patients 132
An exploratory study by DMET array identifies a germline signature associated with imatinib response in gastrointestinal stromal tumor 132
TP53 Alterations Including Missense Mutations, Aberrant Exon-Junctions and Internal Intron Retentions Are Frequent and May Contribute to MDM2 Antagonist-Resistance in B-Acute Lymphoblastic leukemia 112
Down-Regulation of BMI-1 Is a New Marker of Sensitivity to Mdm2 Inhibition in B-Acute Lymphoblastic Leukemia. 107
Down-Regulation of BMI-1 Is a New Marker of Sensitivity to Mdm2 Inhibition in B-Acute Lymphoblastic Leukemia. 106
LOSS OF CDKN2A GENE IS A POOR PROGNOSTIC MARKER IN ADULT BCR-ABL1 POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) PATIENTS 103
MULTIPLEX PCR TO RAPIDLY IDENTIFY IKZF1 (IKAROS) GENE BREAKPOINTS IN BCRABL1-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) 98
SEVERAL FUSION TRANSCRIPTS ARE DETECTED BY NEXT GENERATION PAIRED END TRANSCRIPTOMIC RE-SEQUENCING APPROACH IN ADULT BCR-ABL1-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) 86
NEXT GENERATION PAIRED END TRANSCRIPTOMIC RE-SEQUENCING TECHNOLOGY REVEALS NOVEL COMMON GENETIC ALTERATIONS IN THE HEDGEHOG PATHWAY IN ADULT BCR-ABL1 POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) 80
Totale 1.463
Categoria #
all - tutte 3.385
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.385


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020207 0 0 0 0 31 21 31 25 41 20 18 20
2020/2021234 33 5 3 0 7 7 9 16 19 10 6 119
2021/2022239 23 3 10 13 28 19 4 13 7 22 50 47
2022/2023349 31 68 14 41 17 28 13 18 45 9 34 31
2023/202471 7 13 0 8 6 17 3 5 1 2 5 4
2024/2025161 30 41 26 22 42 0 0 0 0 0 0 0
Totale 1.463